Aldeyra Therapeutics Inc (ALDX)

NASDAQ · Health Care

$0.56 -14.99% Close Oct 30, 2026 Live

Aldeyra Therapeutics stock today

Aldeyra Therapeutics closed at $0.56 on October 30, 2026, down 14.99% on the day. Over the past year it returned -88.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $34.0 million.

$2.00$4.00
NovJan 2026MarMayJulSep
Total return with dividends reinvested, to the close on Oct 30, 2026
PeriodALDXS&P 500 (SPY)
1 month-54.4%-0.9%
3 months-65.0%+2.1%
Year to date-89.2%+11.7%
1 year-88.9%+12.4%
3 years-63.6%+88.5%
5 years-93.8%+76.0%

Key statistics

Market value
$34.0M
52-week range
$0.56 to $5.62
Next report
Nov 4, 2026 (estimated)

About Aldeyra Therapeutics

Develops and commercializes immunology and ophthalmology pharmaceutical treatments.

Sector: Health Care

More on Aldeyra Therapeutics

No forecast, no recommendation. This page describes Aldeyra Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.